• Find an Expert
  • Contact
  • SearchSearch icon
  • Menu
  • Help
  • Report an issue

Contact


Email

jane.mckenzie@unimelb.edu.au

Credentials


Position
Honorary (Fellow)
Department of Medical Biology (WEHI)

Dr Jane McKenzie

Honorary (Fellow)
Department of Medical Biology (WEHI)

14 Scholarly works
1 Projects

HIGHLIGHTS

  • 2026

    Journal article

    Re: Niraparib and Abiraterone Acetate plus Prednisone for HRR-deficient Metastatic Castration-sensitive Prostate Cancer: A Randomized Phase 3 Trial
    DOI: 10.1016/j.eururo.2025.12.008
  • 2026

    Journal article

    Pembrolizumab in metastatic hormone-sensitive prostate cancer: lessons from the negative KEYNOTE-991 trial
    DOI: 10.21037/tau-2025-aw-751
  • 2026

    Journal article

    Cytoplasmic versus nuclear localization of androgen receptor splice variant 7 as a predictor of benefit from androgen receptor pathway inhibitors in metastatic castration-resistant prostate cancer (PROPHECY trial)
    DOI: 10.1038/s41391-026-01113-8
  • 2026

    Research grants (ARC, NHMRC, MRFF)

    Understanding Biomarkers of Response and Resistance to 177-Lutetium-Psma (LuPSMA) in Metastatic Castrate-Resistant Prostate Cancer
  • 2025

    Journal article

    Exploring Real-World Outcomes of First Line EGFR Inhibitor Use, Cetuximab Versus Panitumumab, in Patients with Left-Sided, RAS Wild-Type, Metastatic Colorectal Cancer
    DOI: 10.1016/j.clcc.2025.04.001
  • 2025

    Journal article

    Treatment patterns and outcomes for younger patients with metastatic castration-resistant prostate cancer (mCRPC); An Australian prospective registry study
    DOI: 10.1016/j.clgc.2025.102345
  • 2025

    Conference Proceedings

    Real-world induction targeted therapy (TT) with immune checkpoint inhibitor (ICI) therapy switch in BRAF-mutant metastatic melanoma.
    DOI: 10.1200/JCO.2025.43.16_suppl.e21525
Jane McKenzie

RECENT SCHOLARLY WORKS

  • 2025

    Journal article

    Preventive medication deprescribing in advanced cancer patients approaching end of life
    DOI: 10.1111/imj.70013
  • 2024

    Journal article

    Chemomobilisation Using Gemcitabine-Oxaliplatin for Salvage High Dose Chemotherapy and Autologous Stem Cell Transplant in Advanced Testicular Germ Cell Cancer
    DOI: 10.1016/j.clgc.2024.102234
  • 2024

    Journal article

    Case of the month from the Department of Medical Oncology, Peter MacCallum Cancer Centre, University of Melbourne, Australia: recurrent metastatic spermatocytic tumour successfully treated with salvage systemic chemotherapy
    DOI: 10.1111/bju.16390
  • 2024

    Journal article

    Primary thoracic aorta angiosarcoma presenting with thromboembolism and progressive claudication despite anticoagulation
    DOI: 10.1111/1754-9485.13642

Acknowledgement of Country

We acknowledge Aboriginal and Torres Strait Islander people as the Traditional Owners of the unceded lands on which we work, learn and live. We pay respect to Elders past, present and future, and acknowledge the importance of Indigenous knowledge in the Academy.

Read about our Indigenous priorities

About us  

Careers at Melbourne  

Safety and respect  

Newsroom  

Contact  

Campus locations  

Phone: 13 MELB ( 13 6352)

International: +61 3 9035 5511


Address:
The University of Melbourne
Grattan Street, Parkville,
Victoria, 3010, Australia

facebookIconlinkedinIconinstagramIcon

Emergency information  |  Disclaimer and copyright  |  Accessibility  |  Privacy

CRICOS number: 00116K     ABN: 84 002 705 224